Skip to main content

Table 3 Adverse Events, at Least Possibly Related to Treatment with Avelumab

From: Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

Adverse Event

Grade 1

Grade 2

Grade 3

Grade 4

Tumor pain

1 (13%)

   

Back pain

 

1 (13%)

  

Extremity pain

1 (13%)

   

Fever

1 (13%)

   

Flu-like symptoms

1 (13%)

   

Chills

1 (13%)

   

Fatigue

3 (38%)

1 (13%)

  

Nausea

1 (13%)

   

Wheezing

1 (13%)

   

Bronchial infection

 

1 (13%)

  

Ear and labyrinth disorder (fullness)

 

1 (13%)

  

Urinary urgency

 

1 (13%)

  

Autoimmune disorder

  

3 (38%)

2 (25%)

Hypokalemia

   

1 (13%)

Hypomagnesemia

 

1 (13%)